Blocking TGFβR synergistically enhances anti-tumor effects of anti-PD-1 antibody in a mouse model of incomplete thermal ablation
Open Access
- 30 June 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 138, 112585
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Microwave ablation versus laparoscopic resection as first‐line therapy for solitary 3–5‐cm HCCHepatology, 2022
- Ki-67 protein as a tumour proliferation markerClinica Chimica Acta, 2019
- TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinomaEBioMedicine, 2019
- Local tumour progression after ultrasound-guided microwave ablation of liver malignancies: risk factors analysis of 2529 tumoursEuropean Radiology, 2014
- Percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: A long-term follow-upEuropean Journal of Radiology, 2014
- Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factorsEuropean Radiology, 2012
- Inhibition of Transforming Growth Factor β Receptor I Kinase Blocks Hepatocellular Carcinoma Growth Through Neo-angiogenesis Regulation†Hepatology, 2009
- Blocking transforming growth factor–beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cellsHepatology, 2008
- Laminin-5 stimulates hepatocellular carcinoma growth through a different function of α6β4 and α3β1 integrinsHepatology, 2007
- Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locationsHepatology, 2006